📣 VC round data is live. Check it out!

Cosma Valuation Multiples

Discover revenue and EBITDA valuation multiples for Cosma and similar public comparables like Skin Elements, Lavena - Shumen, Delko, EZZ Life Science and more.

Cosma Overview

About Cosma

Cosma SA, formerly Vabun SA is a Poland-based company involved in the distribution of cosmetics for men and women with the brand name RM Vabun. The product portfolio of the company includes Perfumed Vabun Classic gel, Perfumed Vabun Gold gel, Perfume Vabun Classic, Vabun Sport set, and Mega Perfume Set Vabun Man & Lady.


Founded

2015

HQ

Poland

Employees

N/A

Website

vabun.pl

Financials (FY)

Revenue: $5M
EBITDA: ($806K)

EV

$16M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cosma Financials

Cosma reported last fiscal year revenue of $5M and negative EBITDA of ($806K).

In the same fiscal year, Cosma generated $3M in gross profit, ($806K) in EBITDA losses, and had net loss of ($1M).


Cosma P&L

In the most recent fiscal year, Cosma reported revenue of $5M and EBITDA of ($806K).

Cosma is unprofitable as of last fiscal year, with gross margin of 64%, EBITDA margin of (17%), and net margin of (29%).

See analyst estimates for Cosma
Last FY202320242025202620272028
Revenue$5M$717K$2M$5M
Gross Profit$3M$424K$904K$3M
Gross Margin64%59%46%64%
EBITDA($806K)($12M)($7M)($806K)
EBITDA Margin(17%)(1641%)(337%)(17%)
EBIT Margin(24%)(1644%)(139%)(24%)
Net Profit($1M)($12M)($7M)($1M)
Net Margin(29%)(1656%)(349%)(29%)
Net Debt$940K---

Financial data powered by Morningstar, Inc.

Cosma Stock Performance

Cosma has current market cap of $15M, and enterprise value of $16M.

Market Cap Evolution


Cosma's stock price is $0.10.

Cosma share price decreased by 4.5% in the last 30 days, and by 18.3% in the last year.

Cosma has an EPS (earnings per share) of $-0.01.

See more trading valuation data for Cosma
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$16M$15M-0.2%-4.5%-16.8%-18.3%$-0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cosma Valuation Multiples

Cosma trades at 3.4x EV/Revenue multiple, and (19.9x) EV/EBITDA.

See NTM and 2027E valuation multiples for Cosma

Cosma Financial Valuation Multiples

As of June 3, 2026, Cosma has market cap of $15M and EV of $16M.

Cosma has a P/E ratio of (11.5x).

Last FY202320242025202620272028
EV/Revenue3.4x22.4x8.2x3.4x
EV/EBITDA(19.9x)(1.4x)(2.4x)(19.9x)
EV/EBIT(14.3x)(1.4x)(5.9x)(14.3x)
EV/Gross Profit5.4x37.9x17.8x5.4x
P/E(11.5x)(1.3x)(2.3x)(11.5x)
EV/FCF(24.1x)(10.7x)(8.7x)(24.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cosma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cosma Margins & Growth Rates

In the most recent fiscal year, Cosma reported gross margin of 64%, EBITDA margin of (17%), and net margin of (29%).

See estimated margins and future growth rates for Cosma

Cosma Margins

Last FY20242025202720282029
Gross Margin64%46%64%
EBITDA Margin(17%)(337%)(17%)
EBIT Margin(24%)(139%)(24%)
Net Margin(29%)(349%)(29%)
FCF Margin(14%)(95%)(14%)

Cosma Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth174%138%
Gross Profit Growth113%230%
EBITDA Growth(44%)(88%)
EBIT Growth(77%)(59%)
Net Profit Growth(42%)(80%)
FCF Growth24%(64%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Cosma Operational KPIs

Access forward-looking KPIs for Cosma
Last FY202320242025202620272028
Opex to Revenue88%1703%185%88%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Skin Elements42.1x-(12.1x)-
Lavena - Shumen0.8x-4.8x-
Delko0.2x-5.7x-
EZZ Life Science0.2x0.3x1.4x-
Promisia Healthcare5.6x-16.5x-
Big Tree Cloud Holdings2.8x-(0.2x)-
Natural Health Trends0.1x-(2.3x)-
Aroma0.4x-3.2x-

This data is available for Pro users. Sign up to see all Cosma competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cosma

When was Cosma founded?Cosma was founded in 2015.
Where is Cosma headquartered?Cosma is headquartered in Poland.
Is Cosma publicly listed?Yes, Cosma is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of Cosma?Cosma trades under COS ticker.
When did Cosma go public?Cosma went public in 2018.
Who are competitors of Cosma?Cosma main competitors include Skin Elements, Lavena - Shumen, Delko, EZZ Life Science, Promisia Healthcare, Big Tree Cloud Holdings, Natural Health Trends, Aroma, La savonnerie de Nyons, Highlander Enterprise.
What is the current market cap of Cosma?Cosma's current market cap is $15M.
What is the current revenue of Cosma?Cosma's last fiscal year revenue is $5M.
What is the current EV/Revenue multiple of Cosma?Current revenue multiple of Cosma is 3.4x.
Is Cosma profitable?No, Cosma is not profitable.
How many companies Cosma has acquired to date?Cosma hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Cosma has invested to date?Cosma hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Cosma

Lists including Cosma

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial